Abstract
The present study was carried out through a bibliographic survey of medicinal species, Asystasia gangetica, Catharanthus roseus, Arctium minus, Cynara scolymus, Anredera baselloides, Opuntia ficus-indica, Carica papaya, Ipomoea carnea, Ocimum gratissimum, Abelmoschus esculentus, Musa paradisiaca, Psidium cattleyanum, Syzygium cumini, Bougainvillea glabra, Bougainvillea spectabilis, Phyllanthus niruri, Capsicum baccatum var. pendulum and Zingiber officinale grown in the medicinal garden of Campus 2 of Universidade Paranaense, located in Umuarama, Paraná State, Brazil. The following databases were used for the bibliographic review: Scielo, Medline/Pubmed, and Google Scholar. All the species presented have hypoglycemic activity verified with preclinical and/or clinical pharmacological studies and have great potential for use in the treatment of diabetes or in combination with allopathic drugs. However, despite the pharmacological records found, additional scientific investigations are still needed to be able to use these species more safely and effectively.
Highlights
The use of medicinal plants in the treatment of diseases is a practice as old as humanity itself.The peoples of ancient civilizations already used plants to treat various diseases, and their knowledge was passed on from generation to generation (Feijóet al., 2012).Over time and the advancement of allopathic medicine, these values have been lost, giving way to more modern medicines
The present study was carried out through a bibliographic survey of medicinal species, Asystasia gangetica, Catharanthus roseus, Arctium minus, Cynara scolymus, Anredera baselloides, Opuntia ficus-indica, Carica papaya, Ipomoea carnea, Ocimum gratissimum, Abelmoschus esculentus, Musa paradisiaca, Psidium cattleyanum, Syzygium cumini, Bougainvillea glabra, Bougainvillea spectabilis, Phyllanthus niruri, Capsicum baccatum var. pendulum and Zingiber officinale grown in the medicinal garden of Campus 2 of Universidade Paranaense, located in Umuarama, Paraná State, Brazil
Decree 5,813, of June 22, 2006, on the National Policy on Medicinal Plants and Phytotherapics, which encourages research associated with technological development, which aims to ensure the effectiveness of treatments for low-severity diseases as well as for treatment of chronic diseases, including diabetes (Brasil, 2006)
Summary
The use of medicinal plants in the treatment of diseases is a practice as old as humanity itself.The peoples of ancient civilizations already used plants to treat various diseases, and their knowledge was passed on from generation to generation (Feijóet al., 2012).Over time and the advancement of allopathic medicine, these values have been lost, giving way to more modern medicines. Public policies on the use of medicinal plants and herbal medicines were created by the Brazilian government, so that the population can achieve safe, effective and quality access to these therapeutic resources (Brasil, 2016). On May 3, 2006, the Ministry of Health Ordinance No 971 was published, approving the National Policy on Integrative and Complementary Practices (NPICP), which provides support for the implementation of the national list of medicinal plants and herbal medicines, in addition, recognizes the use of these therapeutic options as an official treatment practice and promotes inclusion to users of the Unified Health System (SUS). Decree 5,813, of June 22, 2006, on the National Policy on Medicinal Plants and Phytotherapics, which encourages research associated with technological development, which aims to ensure the effectiveness of treatments for low-severity diseases as well as for treatment of chronic diseases, including diabetes (Brasil, 2006)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
